Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis-Reference-Cited by-同舟云学术

Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis

Published:2010-06-14 Issue:10 Volume:11 Page:1611-1620
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Abe Masanori,Okada Kazuyoshi,Maruyama Takashi,Maruyama Noriaki,Soma Masayoshi,Matsumoto Koichi

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.2010.495119

Reference27 articles.

1. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

2. Rosiglitazone Reduces Insulin Requirement and C-Reactive Protein Levels in Type 2 Diabetic Patients Receiving Peritoneal Dialysis

3. The Clinical Significance of PPAR Gamma Agonism

4. Insulin Resistance as an Independent Predictor of Cardiovascular Mortality in Patients with End-Stage Renal Disease

5. Metabolic and Additional Vascular Effects of Thiazolidinediones

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease;World Journal of Diabetes;2023-04-15

2. Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022;Diabetic Medicine;2022-12-23

3. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials;BMJ;2021-01-13

4. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease;Cochrane Database of Systematic Reviews;2018-09-24

5. Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future;Critical Reviews in Toxicology;2017-08-17